High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers

被引:11
|
作者
Tokunaga, Eriko [1 ]
Okada, Satoko [1 ]
Yamashita, Nami [1 ]
Akiyoshi, Sayuri [1 ]
Kitao, Hiroyuki [2 ]
Morita, Masaru [1 ]
Kakeji, Yoshihiro [1 ]
Maehara, Yoshihiko [1 ]
机构
[1] Kyushu Univ, Dept Surg & Sci, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Dept Mol Oncol, Grad Sch Med Sci, Fukuoka 8128582, Japan
关键词
Loss of heterozygosity; Human epidermal receptor-2; Triple-negative breast cancer; Genetic instability; Breast cancer subtype; FLUORESCENT MICROSATELLITE ANALYSIS; DINUCLEOTIDE REPEAT INSTABILITY; DNA MISMATCH REPAIR; GENOME-WIDE SEARCH; PROGESTERONE-RECEPTOR; GASTRIC-CANCER; HETEROZYGOSITY; EXPRESSION; CARCINOMA; BRCA1;
D O I
10.1007/s12282-010-0232-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Basal-like and HER2-overexpressing breast carcinomas are histologically undifferentiated, high-grade tumors with a high proliferation rate and associated with a poor outcome. Most basal-like tumors lack the expression of ER, PR, and HER2 (triple-negative; TN). Loss of heterozygosity (LOH) is thought to reflect random chromosomal instability, and recent studies have shown that DNA-copy number alterations or LOH occur with a high frequency in basal-like and HER2-amplified tumors. The levels and patterns of LOH were analyzed by the microsatellite alteration analysis using fluorescence-labeled primers and an automated DNA sequencer at 5 randomly selected loci in 246 Japanese primary breast cancers. Associations between the level of LOH and breast cancer subtypes and tumor aggressiveness were investigated. The incidence and frequency of LOH was significantly higher in HER2 (56.3, 26.7%) and TN groups (44.4, 27.1%) than in luminal A (ER-positive and/or PR-positive and HER2-negative) groups (32.0, 12.2%). The incidence and frequency of LOH increased as nuclear grade was elevated. There were significantly more grade 3 tumors in the HER2 (80.0%) and TN (68.2%) subgroups (p < 0.0001). Even in HER2 and TN cases, the incidence and frequency of LOH was significantly higher in nuclear grade 3 cases than in grade 1 or 2 cases. Relapse-free survival of patients with LOH was significantly shorter than for those without LOH. In addition, the survival time was shorter as the frequency of LOH elevated. The incidence of LOH was an independent prognostic factor for relapse-free survival by multivariate analysis. High incidence and frequency of LOH, which indicate increased genetic instability, were found to be associated with the aggressive features of high-grade HER2 and TN breast cancers.
引用
收藏
页码:161 / 169
页数:9
相关论文
共 50 条
  • [21] Myelin expression factor 2 expression is associated with aggressive phenotype in triple-negative breast cancer
    Chung, Yumin
    Rehman, Abdul
    Ahn, Hyein
    Sim, Jongmin
    Chung, Min Sung
    Choi, Dongho
    Paik, Seung Sam
    Jang, Kiseok
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (04): : 4682 - 4687
  • [22] CLINICOPATHOLOGICAL AND ULTRASONIC FEATURES OF TRIPLE-NEGATIVE BREAST CANCERS: A COMPARISON WITH HORMONE RECEPTOR-POSITIVE/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2-NEGATIVE BREAST CANCERS
    Wang, Dongmo
    Zhu, Kai
    Tian, Jiawei
    Li, Ziyao
    Du, Guoqing
    Guo, Qiang
    Wu, Tong
    Li, Juan
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2018, 44 (05) : 1124 - 1132
  • [23] The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients
    Anna Machleidt
    Stefan Buchholz
    Simone Diermeier-Daucher
    Florian Zeman
    Olaf Ortmann
    Gero Brockhoff
    BMC Cancer, 13
  • [24] Multiple Cancer/Testis Antigens Are Preferentially Expressed in Hormone-Receptor Negative and High-Grade Breast Cancers
    Chen, Yao-Tseng
    Ross, Dara S.
    Chiu, Rita
    Zhou, Xi K.
    Chen, Yunn-Yi
    Lee, Peishan
    Hoda, Syed A.
    Simpson, Andrew J.
    Old, Lloyd J.
    Caballero, Otavia
    Neville, A. Munro
    PLOS ONE, 2011, 6 (03):
  • [25] Immunohistochemistry in the Differential Diagnosis of Triple Negative Breast Carcinoma and High-grade Serous Carcinoma: Old and New Markers
    Jain, Pragya Virendrakumar
    Molina, Mariel
    Moh, Michelle
    Bishop, Erin
    Rader, Janet S.
    Jorns, Julie M.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2024, 32 (10) : 456 - 461
  • [26] Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
    Johanna Alanko
    Minna Tanner
    Ritva Vanninen
    Anssi Auvinen
    Jorma Isola
    Breast Cancer Research and Treatment, 2021, 187 : 267 - 274
  • [27] Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
    Alanko, Johanna
    Tanner, Minna
    Vanninen, Ritva
    Auvinen, Anssi
    Isola, Jorma
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 187 (01) : 267 - 274
  • [28] Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences
    Serio, Pedro Adolpho de Menezes Pacheco
    de Lima Pereira, Glaucia Fernanda
    Katayama, Maria Lucia Hirata
    Roela, Rosimeire Aparecida
    Maistro, Simone
    Folgueira, Maria Aparecida Azevedo Koike
    CELLS, 2021, 10 (12)
  • [29] HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles
    Zhang, Huina
    Katerji, Hani
    Turner, Bradley M.
    Audeh, William
    Hicks, David G.
    MODERN PATHOLOGY, 2022, 35 (08) : 1075 - 1082
  • [30] Establishment and characterization of novel highly aggressive HER2-positive and triple-negative breast cancer cell lines
    Thongchot, Suyanee
    Jamjuntra, Pranisa
    Prasopsiri, Jaturawitt
    Thuwajit, Peti
    Sawasdee, Nunghathai
    Poungvarin, Naravat
    Warnnissorn, Malee
    Sa-Nguanraksa, Doonyapat
    O-Charoenrat, Pornchai
    Yenchitsomanus, Pa-Thai
    Thuwajit, Chanitra
    ONCOLOGY REPORTS, 2021, 46 (06)